Greffrey S. Gilmartin - Net Worth and Insider Trading
Greffrey S. Gilmartin Net Worth
The estimated net worth of Greffrey S. Gilmartin is at least $828 dollars as of 2024-12-13. Greffrey S. Gilmartin is the Chief Development Officer of Proteostasis Therapeutics Inc and owns about 746 shares of Proteostasis Therapeutics Inc (PTI) stock worth over $828. Details can be seen in Greffrey S. Gilmartin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Greffrey S. Gilmartin has not made any transactions after 2019-02-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Greffrey S. Gilmartin
Greffrey S. Gilmartin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Greffrey S. Gilmartin owns 3 companies in total, including Proteostasis Therapeutics Inc (PTI) , Yumanity Therapeutics Inc (YMTX) , and Kineta Inc (KANT) .
Click here to see the complete history of Greffrey S. Gilmartin’s form 4 insider trades.
Insider Ownership Summary of Greffrey S. Gilmartin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTI | Proteostasis Therapeutics Inc | 2020-03-02 | Chief Medical Officer |
| YMTX | Yumanity Therapeutics Inc | 2016-10-21 | Chief Development Officer |
| KANT | Kineta Inc | 2016-10-21 | Chief Development Officer |
Greffrey S. Gilmartin Latest Holdings Summary
Greffrey S. Gilmartin currently owns a total of 1 stock. Greffrey S. Gilmartin owns 746 shares of Proteostasis Therapeutics Inc (PTI) as of February 4, 2019, with a value of $828.
Latest Holdings of Greffrey S. Gilmartin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTI | Proteostasis Therapeutics Inc | 2019-02-04 | 746 | 1.11 | 828 |
Holding Weightings of Greffrey S. Gilmartin
Greffrey S. Gilmartin Form 4 Trading Tracker
According to the SEC Form 4 filings, Greffrey S. Gilmartin has made a total of 0 transactions in Proteostasis Therapeutics Inc (PTI) over the past 5 years. The most-recent trade in Proteostasis Therapeutics Inc is the sale of 459 shares on February 4, 2019, which brought Greffrey S. Gilmartin around $27,475.
Insider Trading History of Greffrey S. Gilmartin
- 1
Greffrey S. Gilmartin Trading Performance
Greffrey S. Gilmartin Ownership Network
Ownership Network List of Greffrey S. Gilmartin
Ownership Network Relation of Greffrey S. Gilmartin
Greffrey S. Gilmartin Owned Company Details
What does Proteostasis Therapeutics Inc do?
Who are the key executives at Proteostasis Therapeutics Inc?
Greffrey S. Gilmartin is the Chief Medical Officer of Proteostasis Therapeutics Inc. Other key executives at Proteostasis Therapeutics Inc include Interim Head of Finance Michael Alfieri , director & President and CEO Meenu Chhabra , and Chief Scientific Officer Benito Munoz .
Proteostasis Therapeutics Inc (PTI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Proteostasis Therapeutics Inc Insider Transactions
Greffrey S. Gilmartin Mailing Address
Above is the net worth, insider trading, and ownership report for Greffrey S. Gilmartin. You might contact Greffrey S. Gilmartin via mailing address: 200 Technology Square, 4th Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
